289 Mucormycosis of the Breast in a Patient With Breast Carcinoma After COVID-19 Pneumonia
-
Published:2022-07-01
Issue:3
Volume:18
Page:289-291
-
ISSN:2587-0831
-
Container-title:European Journal of Breast Health
-
language:
-
Short-container-title:EJBH
Author:
Somashekhar SPORCID, Jaiswal RichaORCID, Kumar Rohit, Ashok BC, Rakshit Susmita, Rauthan Amit, Karthik HK, Prasad Archa, Islam Herra, Fernandes Aaron, Saldahana Elroy, Ashwin KR
Publisher
Galenos Yayinevi
Subject
Ocean Engineering
Reference10 articles.
1. 1. Dulski TM, DeLong M, Garner K, Patil N, Cima MJ, Rothfeldt L, et al. Notes from the Field: COVID-19-Associated Mucormycosis - Arkansas, July-September 2021. MMWR Morb Mortal Wkly Rep 2021; 70: 1750-1751. (PMID: 34914674) [Crossref] 2. 2. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. J Fungi (Basel) 2020; 6: 265. (PMID: 33147877). [Crossref] 3. 3. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021; 15: 102146. (PMID: 34192610). [Crossref] 4. 4. Kubin CJ, McConville TH, Dietz D, Zucker J, May M, Nelson B, et al. Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infect Dis 2021; 8: ofab201. (PMID: 34099978). [Crossref] 5. 5. Song G, Liang G, Liu W. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia 2020; 185: 599-606. (PMID: 32737747). [Crossref]
|
|